Researchers conducted a retrospective study to assess serum inflammatory biomarkers in patients with different subtypes of ...
GlobalData on MSN3mon
MSD and EyeBio launch trial of Restoret for diabetic macular oedemaMSD (Merck & Co) and its wholly-owned subsidiary EyeBio have announced the start of the Phase IIb/III BRUNELLO clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback